← back to search

Rebecca Walwyn

University of Leeds · GB
Area of research
Endocrinology, Diabetes and Metabolism · Economics and Econometrics
Research interest
Research interests include Diabetes Management and Education, Health Systems, Economic Evaluations, Quality of Life, Dementia and Cognitive Impairment Research, and Down syndrome and intellectual disability research.
h-index
25
citations
2,567
works
128
NIH funding
primary concept
email

Recent publications

Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy
BMC Health Services Research 2022cited by 27position: middledoi
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT
Health Technology Assessment 2020cited by 52position: middledoi
Validation of the Cohen-Mansfield Agitation Inventory Observational (CMAI-O) tool
International Psychogeriatrics 2019cited by 46position: middledoi
The Clinical and Cost Effectiveness of Dementia Care Mapping (DCM™) to Reduce Agitation in Care Home Residents with Dementia: Results of the DCM™ EPIC Cluster Randomised Controlled Trial
SSRN Electronic Journal 2018cited by 0position: middledoi
Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes: study protocol for a randomised controlled trial
Trials 2016cited by 33position: middledoi
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
Health Technology Assessment 2013cited by 234position: middledoi
A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan
Trials 2013cited by 30position: firstdoi
Randomized controlled double‐blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability
Journal of Child Psychology and Psychiatry 2012cited by 114position: middledoi
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial
The British Journal of Psychiatry 2012cited by 52position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Clive Ballard · University of Exeter4 papers (2012–2020)Ivana Holloway · University of Leeds3 papers (2016–2020)Amanda Farrin · University of Edinburgh3 papers (2016–2022)Byron Creese · University of Exeter3 papers (2016–2020) · 3 papers (2016–2020)Joanna Murray · Northern Sydney Local Health District2 papers (2012–2013)Michaela Poppe · Queen Mary University of London2 papers (2012–2013) · 2 papers (2012–2013) · 2 papers (2012–2013) · 2 papers (2019–2020)Lynn Chenoweth · UNSW Sydney2 papers (2016–2020)Peter Bentham · University of Birmingham2 papers (2012–2013)Jane Fossey · University of Exeter2 papers (2016–2020) · 2 papers (2016–2020) · 2 papers (2012–2013)Clive Holmes · United States Geological Survey2 papers (2012–2013) · 2 papers (2016–2020)Louise Robinson · Newcastle University2 papers (2016–2020)Gill Livingston · Central and North West London NHS Foundation Trust2 papers (2012–2013)Najma Siddiqi · Indiana University School of Medicine2 papers (2016–2020)